Trials / Completed
CompletedNCT06019156
Effectiveness of Metaverse Space-based Exercise Video Distribution in Young Adults
Effectiveness of Metaverse Space-based Exercise Video Distribution in Young Adults: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Hiroshima University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This study explored whether exercise video distribution using metaverse space is effective in increasing physical activity among young people, along with mental health and locomotive function. This is a randomized parallel-group study. Participants will be assigned to 3 groups: a metaverse group, a YouTube group, and a control group. The metaverse group will receive eight 10-minute exercise videos each week with approximately 4 to 8 METs (metabolic equivalents of task) in the metaverse space to encourage exercise, and the YouTube group will receive access to the same exercise videos as the metaverse group. The control group was given no specific instructions. The intervention period was 8 weeks, and physical activity and other items were measured before and after the intervention. These pre- and post-intervention measurements will be used to determine whether the delivery of exercise videos via Metaverse is effective in increasing physical activity in young adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise video distribution of Metaverse | Participants received a 10-minute exercise video each week with a load of about 4 to 8 metabolic equivalents of task (METs) in the metaverse space, for eight videos delivered to encourage exercise. |
| BEHAVIORAL | Exercise video distribution of YouTube | Participants view exercise videos with the same content as the metaverse group. |
Timeline
- Start date
- 2022-06-13
- Primary completion
- 2022-12-11
- Completion
- 2023-02-10
- First posted
- 2023-08-31
- Last updated
- 2023-08-31
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06019156. Inclusion in this directory is not an endorsement.